Zu "135062-02-1" wurden 3 Artikel gefunden!
Für die Filterung wurden keine Ergebnisse gefunden!
Repaglinide
Artikelnummer: Cay19387-100
Repaglinide is a metaglitinide antidiabetic agent that blocks ATP-dependent potassium (Kir6) channels in pancreatic beta-cells (Kd = 0.42 nM for the sulphonylurea receptor SUR1 when co-expressed with Kir6.2). In vivo, repaglinide lowers blood glucose in fasted rats and dogs (ED50s = 10 and 28.3 µg/kg, respectively)....
| Schlagworte: | 2-ethoxy-4-[2-[[(1S)-3-methyl-1-[2-(1-piperidinyl)phenyl]butyl]amino]-2-oxoethyl]-benzoic acid |
| Anwendung: | Kir6 blocker |
| CAS | 135062-02-1 |
| MW: | 452.6 D |
ab 131,00 €
Repaglinide
Artikelnummer: LKT-R1860.100
Used in treatment of type II diabetes.
| Schlagworte: | Sulfonylurea receptor 1/2 agonist |
| Anwendung: | Antidiabetic [oral hypoglycemic agent] |
| CAS | 135062-02-1 |
| MW: | 452,59 D |
ab 242,00 €
Repaglinide
Artikelnummer: CDX-R0122-M050
White to off-white powder. Soluble in DMSO (30mg/ml), DMF (30mg/ml) or ethanol (20mg/ml). Chemical. CAS: 135062-02-1. Formula: C27H36N2O4. MW: 452.59. Repaglinide is a metaglitinide antidiabetic agent. It is a potent short-acting insulin secretagogue that acts by closing ATP-sensitive potassium (KATP) channels in...
| Schlagworte: | (S)-(+)-2-Ethoxy-4-[N-[1-(2-piperidinophenyl)-3-methyl-1-butyl]aminocarbonylmethyl]benzoic acid, Novonorm, Prandin |
| CAS | 135062-02-1 |
| MW: | 452,59 D |
ab 77,00 €
